Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-25-000019

Chief Technology Officer sold 2,195 shares at $23.59 ($51,780)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stout Jay S Chief Technology Officer 2025-01-22 Sale −2,195 $23.59 $51,780 139,991 D
Open-market sales · 2,195 sh · avg $23.59 · $51,780
Loading xslF345X05/wk-form4_1737753791.xml…